Evolus, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Evolus, Inc. (Nasdaq: EOLS) on September 8, 2025. The report discloses the appointment of a new Chief Financial Officer effective as of the filing date.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and appointment details.
Material Changes
The primary material change reported is the appointment of Tatjana Mitchell as Chief Financial Officer, effective September 8, 2025. Ms. Mitchell previously served as Senior Vice President, Finance of Experian North America.
Management Commentary and Compensation Details
The filing details the terms of the Employment Agreement between Evolus, Inc. and Ms. Mitchell:
- Base Salary: $490,000 annualized.
- Signing Bonus: $100,000 one-time payment, subject to repayment clauses if employment ends prior to the first or second anniversary.
- Annual Bonus: Target opportunity of 55% of base salary, determined by the Board.
- Equity Awards:
- Stock Option: Value of $750,000 based on Black-Scholes valuation; vests in equal annual installments over four years.
- Restricted Stock Units (RSUs): Value of $750,000 based on 30-day average closing price; 50% vests on the third anniversary and 50% on the fourth anniversary.
- Severance Provisions:
- Standard Termination (Without Cause/Good Reason): 12 months of base salary, pro-rated bonus, 12 months of COBRA coverage, and $15,000 outplacement assistance.
- Change in Control Termination: 18 months of base salary, 100% of target bonus, 18 months of COBRA coverage, $15,000 outplacement assistance, and accelerated vesting of all equity awards.
Investor Verification Checklist
- Verify the exact number of shares granted for the Stock Option and RSUs once the Black-Scholes value and 30-day average stock price are finalized.
- Review the full Employment Agreement (to be filed as an exhibit to the Form 10-Q for the quarter ended September 30, 2025) for complete terms.
- Confirm the impact of the new CFO appointment on the company's strategic financial planning in upcoming earnings reports.